Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline with Corticosteroids for Severe Alcoholic Hepatitis
NCT01214226Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in alcoholic hepatitis (AH) comparing Pentoxifylline + Prednisolone with Placebo + Prednisolone (2 arms). Primary endpoint: Overall Survival at 6 months. Started Dec 2007; status: completed.
02
Drugs
pentoxifylline
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT01214226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214226.